B01 RFI Scale -X-Carbo Bioreacto 7.16.2024.doc
DOC document 88 KB Posted
- Attached to
- Scale -X-Carbo Bioreactor
- Solicitation number
- PANMRA_24_P_0000_004848
- Issued by
-
Defense Health Agency
About this file
This document is a Request for Information (RFI) issued by the Defense Health Agency (DHA) to ascertain whether a commercial item exists that provides the capabilities described for a Scale-X-Carbo Bioreactor. The purpose of this requirement is to provide a fixed bed bioreactor for use in adherent cell culture for Good Manufacturing Practice (GMP) production of viral vaccine and therapeutic products to be used in Phase 1 clinical trials. The period of performance is from November 1, 2024 to October 31, 2025.
The RFI requests responses from capable and qualified sources by July 24, 2024. Responses should include technical details demonstrating how the respondent meets the requirements outlined in the attached table. No solicitation currently exists, and no evaluation letters or results will be issued. This RFI is for information and planning purposes only and does not constitute a solicitation or offer. Respondents are responsible for all costs associated with responding to this RFI.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| A02-MECs-Scale-X Carbo Bioreactor.docx | DOCX document |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Request for Information (RFI) Scale -X-Carbo Bioreactor General Information:
This is an RFI as defined in FAR 15.201(e) to ascertain whether a commercial item exists that provides the capabilities described herein.
This RFI is issued solely for information and planning purposes and does not constitute a solicitation. All information received in response to this RFI will be treated as business confidential information. Nonetheless, submitters should properly mark their responses if the information is confidential. Responses to the RFI will not be returned. Responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. Responders are solely responsible for all expense associated with responding to this RFI.
RFI Response and due date: 24 July 2024 Instructions to Responders:
Responses from all capable and qualified sources are encouraged to respond to this request.
White papers should adhere to the following formatting and outline instructions:
1. All submissions shall be made electronically and be in one of the following formats: Microsoft Word or Adobe PDF.
2. Cover Page (1 page)
· Title
· Organization
· Responders technical and administrative points of contact (names, addresses, phone, fax number and email addresses)
· Topic area(s) addressed
· GSA Schedule (if applicable)
3. Completed list of items that contratctor is capable of providing. Please note that the response shall provide sufficient technical data to determine how you fully meet the requirements as specified in table below.
Please note that responses are due no later than 24 July 2024 12:00pm, Eastern. The preferred method of submission is via email, SUBJECT: Scale -X-Carbo Bioreactor. The point of contact for this action is Natalie Bethel, Contract Specialist, Natalie.L.Bethel2@health.mil. Only electronic responses are requested. No evaluation letters and/or results will be issued to the respondents. At this time no solicitation exists; therefore, please do not request a copy of the solicitation. NO PHONE CALLS PLEASE. It is the responsibility of any potential offeror to monitor this site for the release of any solicitation or synopsis.
Background/Overview:
The purpose of this requirement is to provide Scale-X-carbo-bioreactor equipment to include shipping, installation, training, and one year manufacturer warranty. The Pilot Bioproduction Facility(PBF) requires a fixed bed bioreactor for use in adherent cell culture for Good Manufacturing Practice (GMP) production of viral vaccine and therapeutic products to be used in Phase 1 clinical trials.
The period of performance shall be as follows:
Base period 01 Nov 2024 – 31 Oct 2025
- 3 -
File details come from the government source that posted it. Updated .